找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: International Conference on Innovative Computing and Communications; Proceedings of ICICC Ashish Khanna,Deepak Gupta,Aboul Ella Hassanien C

[復(fù)制鏈接]
樓主: Motion
11#
發(fā)表于 2025-3-23 19:46:11 | 只看該作者
12#
發(fā)表于 2025-3-24 02:02:28 | 只看該作者
-malarial and anti-cryptosporidium strategies. Therefore, the development of targeted isoform selective inhibitors for these enzymes are of paramount importance. The first generation of PI3K inhibitors have recently been clinically approved for a number of different cancers, highlighting their thera
13#
發(fā)表于 2025-3-24 02:54:50 | 只看該作者
Pradeep Kumar Singh,Showmik Setta,Pijush Kanti Dutta Pramanik,Prasenjit Choudhuryfully designed to spare gastrointestinal toxicity, but predisposed patients to increased cardiovascular risks. These health complications from NSAIDs prompted interest in the downstream effectors of the COX enzymes as novel drug targets. This chapter describes various safety issues with tNSAIDs and
14#
發(fā)表于 2025-3-24 10:34:46 | 只看該作者
15#
發(fā)表于 2025-3-24 12:42:07 | 只看該作者
Kumud Tiwari,Sachin Kumar,R. K. Tiwarirchers at Rh?ne Poulenc, who named it rubidomycin. Later on, it became clear that rubidomycin and daunomycin were identical and daunorubicin became the only name for this compound. In 1969, Arcamone and his co-workers succeeded in isolating and purifying doxorubicin (14-hydroxydaunomycin) from . var
16#
發(fā)表于 2025-3-24 16:55:55 | 只看該作者
Muhammad Ali,Waqas Arshadnd related non-steroidal antiinflammatory drug (NSAID:s). is well established, and apparently correlates with the capacity to inhibit the formation of cyclooxygenase products, notably PGE., PGD2, and PGI2. Although these three substances are considered proinflammatory and potently enhance the respon
17#
發(fā)表于 2025-3-24 22:19:50 | 只看該作者
18#
發(fā)表于 2025-3-25 00:23:57 | 只看該作者
19#
發(fā)表于 2025-3-25 05:34:26 | 只看該作者
20#
發(fā)表于 2025-3-25 07:33:44 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 22:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
册亨县| 南投县| 江川县| 云霄县| 舟山市| 宜春市| 大悟县| 梅州市| 瑞安市| 盱眙县| 东乌| 芦溪县| 高阳县| 长泰县| 丁青县| 梁平县| 探索| 尉氏县| 台东市| 太谷县| 京山县| 乌拉特中旗| 油尖旺区| 阳曲县| 忻城县| 安平县| 泰兴市| 东莞市| 噶尔县| 安徽省| 邹城市| 刚察县| 洪泽县| 闵行区| 阿坝县| 哈密市| 北安市| 邹平县| 贵州省| 噶尔县| 成都市|